OLIG2 is a determinant for the relapse of MYC-amplified medulloblastoma. Xu Z, Murad N, Malawsky DS, Tao R, et al. Clin Cancer Res 2022 May 26. pii: 699250. doi: 10.1158/1078-0432.CCR-22-0527.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu Z, Murad N, Malawsky DS, Tao R, et al. OLIG2 is a determinant for the relapse of MYC-amplified medulloblastoma. Clin Cancer Res 2022 May 26. pii: 699250. doi: 10.1158/1078-0432.CCR-22-0527.
PMID: 35617515